29-N general election in Almería How to vote, the calendar and every result since 1977

A 16.44-tesla magnet and two robots: this is what the 2.24 million laboratory will be like

Topics Centro Comercial Torrecárdenas Servicio Andaluz de Salud Universidad de Almería

The UAL provides a 700 MHz nuclear magnetic resonance team and the SAS two sample preparation robots for Torrecárdenas.

AlmeríaYa newsroom ·

Un grupo de catorce personas posa de pie tras una mesa con el logotipo de la Universidad de Almería.
Photo: Universidad de Almería
The University of Almería (UAL) and the Andalusian Health Service (SAS) have signed an agreement to create a Joint Research Platform in Precision Clinical Biomarkers, with a total investment of 2,240,000 euros. The agreement was signed by the rector, José J. Céspedes, and the managing director of the Torrecárdenas University Hospital (HUT), Manuel R. Vida. The money is divided into two parts. The UAL contributes two million euros for the equipment, from a grant from the Ministry of Science, Innovation and Universities. The SAS provides the remaining 240,000 euros for the preanalytics service, which includes two automated sample preparation robots. The heart of the platform is a latest-generation nuclear magnetic resonance (NMR) machine, at 700 MHz and with a 16.44 tesla magnet, installed in the UAL's Central Research Services. It incorporates a cryoprobe and a sampler for up to 500 units. The HUT, for its part, houses the physical headquarters of the Joint Platform Office (OPM) and a permanent operational unit to channel clinical studies. The infrastructure will be used to research oncology, rare diseases, cardiovascular, neurological, metabolic, infectious, endocrine or inflammatory diseases, as detailed by the academic institution. The aim is for it to serve researchers and healthcare professionals at regional and national level. The agreement has an initial term of four years from its signing and may be extended by express agreement for a further four. Ownership of the results and data from the research will correspond equally to the UAL and the SAS. Céspedes has stated that the platform represents "a new bridge between academic research and real clinical practice". Vida has stated that the project is "a faithful example" of the hospital's line and that, together with the University, "this is going to be unstoppable".

Shall we let you know what matters?

Phone alerts

Change or remove it in my alerts

1 foto

Foto: Universidad de Almería